Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$592,726
6 notices · 54,033 sh
Oct 2025 to Oct 2026
Reported ·
$181.1M
15 sales · 4 buys · $54,890 bought
Oct 2025 to Jun 2026
The two figures cover different periods.
4 of 15 reported sales carry the 10b5-1 box. Together they are 51.47% of the shares on issue.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
2026-08-18Newton Charles W., Director$5,719
551 shplan 2026-03-12Form 4s on file end Jun 23144 ↗ 2026-06-11Newton Charles W., Director$5,473
550 shplan 2026-03-12144 ↗ Form 4, 2026-06-15: sold 550 at $10.04
Form 4 ↗2026-06-04Farzan Nima, Director$28,035
2,625 shplan 2025-12-05144 ↗ Form 4, 2026-06-08: sold 2,625 at $10.73
Form 4 ↗2026-06-04Knowles Julius, Director$28,035
2,625 shplan 2025-12-05144 ↗ Form 4, 2026-06-08: sold 2,625 at $10.73
Form 4 ↗2026-06-04Seth Alpna, Director$28,035
2,625 shplan 2025-12-09144 ↗ Form 4, 2026-06-05: sold 2,625 at $10.72
Form 4 ↗2026-03-31OrbiMed Genesis Master Fund, LP, Shareholder, Director$497,429
45,057 shno plan dateForm 4s on file end Jun 23144 ↗